Practice – Related Information
- Clinical Practice Center by the American Academy of Child and Adolescent Psychiatry
- Centerwatch clinical trials information
- Organizations and Meeting in psychiatry
- Practice Management by the American Psychiatric Association
- Practice Parameters by the American Academy of Child and Adolescent Psychiatry
Major Pediatric Psychopharmacological Trials
- Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS.
- Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study.
- The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation.
- Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study.
- A 14-month randomized clinical trial of treatment strategies for attention–deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.
- 3-year follow-up of the NIMH MTA study.
- The MTA at 8 years: prospective follow-up of children treated for combined-type ADHDin a multisite study.
- Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
- Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I).
- Predictors of parental accommodation in pediatric obsessive-compulsive disorder: findings from the Pediatric Obsessive-Compulsive Disorder Treatment Study (POTS) trial.
- Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.
- Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents withdepression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
- The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.
- The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.
- A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.
- Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study.
- Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study.
- Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.
- Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.
- Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
- Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review.
- Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.
Where to find us
Opening Hours
Mo-Fr: 8:00-22:00
Sa: 8:00-24:00
So: 8:00-14:00
Contact Us
1655 N. Main Street, Suite 200,
Walnut Creek, CA 94596
Phone : 925-385-8574
Fax : 925-307-5276
Email : info@baypsychiatry.com